Biosynthetic pathway of 2-deoxystreptamine

Area of Science:

• Microbiology
• Biochemistry
• Molecular Biology

Background:

• 2-deoxystreptamine (DOS) is a crucial component of aminoglycoside antibiotics like butirosins.
• Understanding the biosynthesis pathway of DOS is essential for antibiotic production.
• A mutant strain of Bacillus circulans lacking functional DOS biosynthesis was utilized.

Purpose of the Study:

• To identify and confirm intermediates in the 2-deoxystreptamine (DOS) biosynthesis pathway.
• To investigate the role of S-11-P in the production of DOS.
• To elucidate the relationship between S-11-P, DOS, and butirosin synthesis.

Main Methods:

• Supplementation of four 2-deoxystreptamine (DOS)-related compounds, including S-11-P, to cultures of a DOS-mutant of Bacillus circulans.
• Analysis of the conversion of supplemented compounds to DOS.
• Assessment of the effect of other aminocyclitols on S-11-P and DOS incorporation into butirosins.

Main Results:

• S-11-P was the only tested compound that was converted to 2-deoxystreptamine (DOS) by the Bacillus circulans mutant.
• The addition of other aminocyclitols did not produce antibiotic activity.
• Other aminocyclitols did not inhibit the incorporation of S-11-P and DOS into butirosins.

Conclusions:

• S-11-P is definitively confirmed as an intermediate in the biosynthesis of 2-deoxystreptamine (DOS).
• This finding clarifies a critical step in the DOS biosynthetic pathway.
• The results support the potential for metabolic engineering of antibiotic production.